Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.

MLA

Barbarisi, Manlio, et al. “Novel Nanohydrogel of Hyaluronic Acid Loaded with Quercetin Alone and in Combination with Temozolomide as New Therapeutic Tool, CD44 Targeted Based, of Glioblastoma Multiforme.” Journal of Cellular Physiology, vol. 233, no. 10, Oct. 2018, pp. 6550–64. EBSCOhost, https://doi.org/10.1002/jcp.26238.

APA

Barbarisi, M., Iaffaioli, R. V., Armenia, E., Schiavo, L., De Sena, G., Tafuto, S., Barbarisi, A., & Quagliariello, V. (2018). Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. Journal of Cellular Physiology, 233(10), 6550–6564. https://doi.org/10.1002/jcp.26238

Chicago

Barbarisi, Manlio, Rosario V Iaffaioli, Emilia Armenia, Luigi Schiavo, Gabriele De Sena, Salvatore Tafuto, Alfonso Barbarisi, and Vincenzo Quagliariello. 2018. “Novel Nanohydrogel of Hyaluronic Acid Loaded with Quercetin Alone and in Combination with Temozolomide as New Therapeutic Tool, CD44 Targeted Based, of Glioblastoma Multiforme.” Journal of Cellular Physiology 233 (10): 6550–64. doi:10.1002/jcp.26238.